Effect of MSPrebiotic on Gastrointestinal Function and Blood Glucose Levels
Effect of MSPrebiotic Digestion Resistant Starch on Gastrointestinal Function and Blood Glucose Levels
Sponsor: MSP Starch Products Inc.
A NA clinical study on Gastrointestinal Function, this trial is completed. The trial is conducted by MSP Starch Products Inc. and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
May 2025 — Present [monthly]
Completed NA
-
Sep 2024 — May 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Feb 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Feb 2022 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2019 — Oct 2019 [monthly]
Recruiting NA
First recorded
Apr 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MSP Starch Products Inc.
- Source Nutraceutical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .